Daniel Morgenstern, Associate Professor at University of Toronto, shared a post on LinkedIn about recent paper he and colleagues co-authored, published in Journal of Clinical Oncology.
“Another demonstration of the utility of single patient studies. Many thanks C17 Council and many others for helping make this happen”
Title: Mucin 16–Directed Therapy in Pediatric Sarcomas: Case Evidence of Ubamatamab Efficacy in Epithelioid Sarcoma and Its Implications for Other Sarcoma Subtypes
Authors: Denise M. Connolly, Gabriel Revon-Rivière, Rose Chami, Denise Mills, Ailish C. Coblentz, Thomas S. Uldrick, David A. Knorr, Priscila Goncalves, Michael Dobosz, Sumreen Jalal, Sarah Cohen-Gogo, and Daniel A. Morgenstern
Read The Full Article at Journal of Clinical Oncology.
More posts featuring Sarcoma.